Strong Revenue Growth
Consolidated revenues were $1,002,000,000, up 6% year over year or up 7% organically. CooperVision revenues were $670,000,000, up 5% or 7% organically, and CooperSurgical revenues were $333,000,000, up 8% or 7% organically.
Non-GAAP Earnings Increase
Non-GAAP earnings were $0.96, up 14% year over year, driven by operational improvements and OpEx leverage.
Myopia Management Growth
Myopia management portfolio grew 19% with MiSight up 35%, supported by a new pricing model and increased fitting activity.
Office and Surgical Segment Performance
Office and Surgical sales were $206,000,000, up 13% or 10% organically, driven by minimally invasive gynecological surgical devices and labor and delivery products.
PARAGARD Growth
PARAGARD grew 18% this quarter, driven by channel fill before a price increase and continued interest in the new single hand inserter.